Suppr超能文献

HIV 感染者阻塞性睡眠呼吸暂停的发病机制。

Pathogenesis of obstructive sleep apnea in people living with HIV.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, California.

Sleep and Circadian Medicine Laboratory, Department of Physiology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia.

出版信息

J Appl Physiol (1985). 2021 Dec 1;131(6):1671-1678. doi: 10.1152/japplphysiol.00591.2021. Epub 2021 Oct 21.

Abstract

Obstructive sleep apnea (OSA) is highly prevalent in people living with human immunodeficiency virus (HIV) (PLWH), and it might contribute to frequently reported symptoms and comorbidities. Traditional risk factors for OSA are often absent in PLWH, suggesting that HIV or HIV medications might predispose to OSA. Therefore, we measured the anatomical and nonanatomical traits important for OSA pathogenesis in those with and without HIV. We recruited virally suppressed PLWH who had been previously diagnosed with OSA (PLWH + OSA) adherent to positive airway pressure (PAP) therapy, along with age-, sex-, and body mass index (BMI)-matched OSA controls. All participants underwent a baseline polysomnogram to assess OSA severity and a second overnight research sleep study during which the airway pressure was adjusted slowly or rapidly to measure the OSA traits. Seventeen PLWH + OSA and 17 OSA control participants were studied [median age = 58 (IQR = 54-65) yr, BMI = 30.7 (28.4-31.8) kg/m, apnea-hypopnea index = 46 (24-74)/h]. The groups were similar, although PLWH + OSA demonstrated greater sleepiness (despite PAP) and worse sleep efficiency on baseline polysomnography. On physiological testing during sleep, there were no statistically significant differences in OSA traits (including V, V, V, V, and loop gain) between PLWH + OSA and OSA controls, using mixed-effects modeling to account for age, sex, and BMI and incorporating each repeated measurement (range = 72-334 measures/trait). Our data suggest that well-treated HIV does not substantially impact the pathogenesis of OSA. Given similar underlying physiology, existing available therapeutic approaches are likely to be adequate to manage OSA in PLWH, which might improve symptoms and comorbidities. Clinical data suggest an increased risk of obstructive sleep apnea (OSA) in people living with HIV (PLWH), while OSA might account for chronic health issues in this population. We characterized the anatomical and nonanatomical OSA traits in PLWH + OSA compared with OSA controls, using detailed physiological measurements obtained during sleep. Our data suggest against a major impact of HIV on OSA pathogenesis. Available OSA management strategies should be effective to address this potentially important comorbidity in PLWH.

摘要

阻塞性睡眠呼吸暂停(OSA)在感染人类免疫缺陷病毒(HIV)的人群(PLWH)中极为常见,并且可能导致经常报告的症状和合并症。OSA 的传统危险因素在 PLWH 中常常不存在,这表明 HIV 或 HIV 药物可能导致 OSA。因此,我们测量了那些有和没有 HIV 的人的 OSA 发病机制的解剖和非解剖特征。我们招募了病毒抑制的 PLWH,他们以前被诊断患有 OSA(PLWH + OSA),并坚持使用正压通气(PAP)治疗,同时还招募了年龄、性别和体重指数(BMI)匹配的 OSA 对照组。所有参与者都进行了基线多导睡眠图检查,以评估 OSA 严重程度,并进行了第二次夜间研究性睡眠研究,在此期间,气道压力被缓慢或快速调整,以测量 OSA 特征。研究了 17 名 PLWH + OSA 和 17 名 OSA 对照组参与者[中位数年龄=58(IQR=54-65)岁,BMI=30.7(28.4-31.8)kg/m2,呼吸暂停-低通气指数=46(24-74)/h]。两组相似,尽管 PLWH + OSA 在基线多导睡眠图上表现出更大的嗜睡(尽管使用了 PAP)和睡眠效率更差。在睡眠期间的生理测试中,使用混合效应模型来考虑年龄、性别和 BMI,并结合每个重复测量(范围=72-334 次/特征),使用混合效应模型来考虑年龄、性别和 BMI,并结合每个重复测量(范围=72-334 次/特征),使用混合效应模型来考虑年龄、性别和 BMI,并结合每个重复测量(范围=72-334 次/特征),在统计学上,PLWH + OSA 和 OSA 对照组之间的 OSA 特征(包括 V、V、V、V 和环路增益)没有显著差异。我们的数据表明,经过良好治疗的 HIV 不会对 OSA 的发病机制产生实质性影响。鉴于潜在的生理学相似性,现有的治疗方法可能足以治疗 PLWH 的 OSA,这可能会改善症状和合并症。临床数据表明,HIV 感染者(PLWH)患阻塞性睡眠呼吸暂停(OSA)的风险增加,而 OSA 可能导致该人群的慢性健康问题。我们使用睡眠期间获得的详细生理测量来描述 PLWH + OSA 与 OSA 对照组之间的解剖和非解剖 OSA 特征。我们的数据表明,HIV 对 OSA 发病机制的影响不大。现有的 OSA 管理策略应该能够有效地解决 PLWH 中这一潜在的重要合并症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e28/8714978/89d5c0de4b63/jappl-00591-2021r01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验